Browse Category

NASDAQ:HOLX 21 October 2025 - 9 April 2026

For live price, interactive charts, financials and the latest market data, visit Google Finance.
Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Blackstone’s latest results painted a mixed picture. The firm reported distributable earnings of $1.889 billion, up 48% from a year ago and well above the $1.23 forecastreuters.com. However, on a GAAP basis net income dropped to $624.9 million from $780.8 million last year, and total revenue slid about 15.7% year-over-yearts2.tech. Investors focused on the earnings miss and slowing revenue, which partly offset the beat on cash profit. As a result, BX shares dipped about 1% intraday on Oct. 23, trading around $160benzinga.com.
23 October 2025
···
Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Hologic is a Marlborough, MA–based medical technology firm focused on women’s health. Its products include mammography and breast biopsy systems, cervical cancer tests, surgical equipment, and lab diagnostics including molecular tests for Covid-19 bostonglobe.com. The Blackstone/TPG consortium will buy all outstanding Hologic shares for $76 cash plus a $3 CVR marketscreener.com. This values the deal at $79 per share maximum and around $18.3 billion total enterprise value marketscreener.com. The purchase price represents a roughly 46% premium to Hologic’s share price before takeover rumors marketscreener.com.
21 October 2025
····